LANXESS (LXS) Resumen de Acciones
LANXESS Aktiengesellschaft, junto con sus filiales, opera como empresa de especialidades químicas que se dedica al desarrollo, fabricación y comercialización de productos químicos intermedios, aditivos, especialidades químicas y productos de protección del consumidor en todo el mundo. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 5/6 |
| Crecimiento futuro | 0/6 |
| Rendimiento pasado | 0/6 |
| Salud financiera | 3/6 |
| Dividendos | 0/6 |
LXS Community Fair Values
Create NarrativeSee what 23 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Competidores de LANXESS Aktiengesellschaft
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | €16.11 |
| Máximo en las últimas 52 semanas | €27.14 |
| Mínimo de 52 semanas | €11.03 |
| Beta | 1.14 |
| Cambio en 1 mes | -2.95% |
| Variación en 3 meses | -8.78% |
| Cambio de 1 año | -36.17% |
| Variación en 3 años | -41.74% |
| Variación en 5 años | -72.81% |
| Variación desde la OPV | 8.56% |
Noticias y actualizaciones recientes
Artículo de análisis • Jun 20
LANXESS (XTRA:LXS) Stock Could Be 4.4% Undervalued After Bond Issue And Ownership Shifts
LANXESS (XTRA:LXS) has drawn investor attention after completing a €494.53 million senior unsecured notes offering due 2031, while recent voting rights disclosures from Stowers Institute and JPMorgan highlight shifting institutional ownership. See our latest analysis for LANXESS. At a share price of €17.12, LANXESS has seen a 7.74% 1-day share price return and a 46.95% 90-day share price return, while the 1-year total shareholder return is down 28.67%. This suggests that recent momentum has...
Actualización de narrativa • Jun 17
LXS: Mixed Bank Downgrades Will Drive Bullish Repricing On Middle East Risk
The analyst price target for LANXESS has been reduced by €0.61, as analysts factor in recent downgrades and lower price targets related to concerns about pricing, balance sheet strength and demand risks highlighted in recent research. Analyst Commentary Recent research on LANXESS reflects a cautious tone overall, but there are still some constructive elements that matter for how you think about the stock's valuation and execution risk.
Actualización de narrativa • Jun 02
LXS: Fair Outlook Flags Limited Upside As Middle East Risk Deepens
LANXESS's fair value estimate is revised from €14.0 to €11.0 as analysts reset price targets following multiple downgrades, citing limited perceived upside after the share price rally, along with fresh concerns around pricing, demand resilience, and the balance sheet linked to the Middle East conflict. Analyst Commentary Recent research updates on LANXESS point to a clear shift toward caution, with several large houses cutting ratings and trimming price targets.Recent updates
Artículo de análisis • Jun 20
LANXESS (XTRA:LXS) Stock Could Be 4.4% Undervalued After Bond Issue And Ownership Shifts
LANXESS (XTRA:LXS) has drawn investor attention after completing a €494.53 million senior unsecured notes offering due 2031, while recent voting rights disclosures from Stowers Institute and JPMorgan highlight shifting institutional ownership. See our latest analysis for LANXESS. At a share price of €17.12, LANXESS has seen a 7.74% 1-day share price return and a 46.95% 90-day share price return, while the 1-year total shareholder return is down 28.67%. This suggests that recent momentum has...Actualización de narrativa • Jun 17
LXS: Mixed Bank Downgrades Will Drive Bullish Repricing On Middle East Risk
The analyst price target for LANXESS has been reduced by €0.61, as analysts factor in recent downgrades and lower price targets related to concerns about pricing, balance sheet strength and demand risks highlighted in recent research. Analyst Commentary Recent research on LANXESS reflects a cautious tone overall, but there are still some constructive elements that matter for how you think about the stock's valuation and execution risk.Actualización de narrativa • Jun 02
LXS: Fair Outlook Flags Limited Upside As Middle East Risk Deepens
LANXESS's fair value estimate is revised from €14.0 to €11.0 as analysts reset price targets following multiple downgrades, citing limited perceived upside after the share price rally, along with fresh concerns around pricing, demand resilience, and the balance sheet linked to the Middle East conflict. Analyst Commentary Recent research updates on LANXESS point to a clear shift toward caution, with several large houses cutting ratings and trimming price targets.Artículo de análisis • May 09
Here's What Analysts Are Forecasting For LANXESS Aktiengesellschaft (ETR:LXS) After Its First-Quarter Results
LANXESS Aktiengesellschaft ( ETR:LXS ) shareholders are probably feeling a little disappointed, since its shares fell...Actualización de narrativa • May 01
LXS: Mixed Bank Ratings Will Drive Bullish Repricing On Higher Future P/E
Analysts have adjusted the price target on LANXESS from about €28.86 to about €26.29. This reflects updated views on faster revenue growth, much thinner profit margins, and a much higher assumed future P/E multiple after recent mixed rating changes from major banks.
Actualización de narrativa • Apr 16
LXS: Future Earnings Multiples Will Balance Mixed Ratings And Margin Execution Risk
LANXESS' updated analyst price target edges up to about €17.91 from roughly €17.81, as analysts factor in slightly higher assumed revenue growth and a marginally richer future P/E, partly offset by a more cautious profit margin view following mixed recent rating changes. Analyst Commentary Recent research views on LANXESS are mixed, with both upgrades and a downgrade pointing to different expectations around execution, earnings power and valuation risk.Actualización de narrativa • Apr 02
LXS: Future Earnings Multiples Will Reflect Mixed Rating Shifts And Execution Risk
Analysts have trimmed the LANXESS price target from about €18.66 to around €17.81, reflecting mixed recent research that balances reduced fair value and profit margin assumptions with updated views on growth and valuation following both target cuts and rating changes across the Street. Analyst Commentary Recent research on LANXESS shows a split tape, with some firms turning more positive on the shares while others are taking a more cautious line on execution and fair value assumptions.Actualización de narrativa • Mar 19
LXS: Fair Outlook Balances Higher Risk Assumptions With Recent Upgrade
Analysts have trimmed their fair value estimate for LANXESS from €17.0 to €14.0, reflecting recent price target cuts such as Deutsche Bank's move to €17 and updated assumptions for growth, margins and risk, even as some research, including a recent Goldman Sachs upgrade, highlights potential longer term upside drivers. Analyst Commentary Recent research shows a split view on LANXESS, with some highlighting possible longer term drivers while others are reining in expectations.Actualización de narrativa • Mar 05
LXS: Upgrade And Reset Expectations Will Drive Bullish Repricing Potential
Analysts have adjusted their price targets on LANXESS, with the latest change lowering one view from €18.50 to €17. This reflects updated assumptions around discount rates, modest revenue growth and expected P/E levels.Actualización de narrativa • Feb 18
LXS: Upgrade And Margin Execution Are Expected To Drive Bullish Repricing
LANXESS's consensus analyst price target has moved modestly lower, with recent cuts to €17 and €15 cited by analysts who point to updated assumptions around discount rates, profit margins, and forward P/E expectations. Analyst Commentary Recent research on LANXESS highlights a mix of caution and optimism, with some bullish analysts focusing on potential upside if the company can execute against current expectations on margins and earnings quality.Actualización de narrativa • Feb 04
LXS: Sector Headwinds And Execution Discipline Will Drive Future Bullish Repricing
Analysts have trimmed their price expectations for LANXESS, reflected in a slightly lower fair value estimate of about €28.87 from €29.24. They cite a series of reduced Street price targets and more cautious sector views, even as underlying model assumptions such as revenue growth, profit margin and future P/E remain broadly consistent.Actualización de narrativa • Jan 21
LXS: Future Earnings Multiples Will Reward Execution Despite Sector Downgrades
Our fair value estimate for LANXESS has been reduced from about €20.30 to roughly €18.66, reflecting a cluster of lower price targets and more cautious views from analysts who now generally expect lower growth and apply a slightly higher required return. Analyst Commentary Recent Street research around LANXESS has tilted more cautious, with several firms trimming price targets and highlighting sector headwinds in European chemicals and ingredients.Actualización de narrativa • Jan 06
LXS: Earnings Resilience And Portfolio Actions Will Drive Bullish Repricing
Narrative Update The updated analyst price target framework for LANXESS points to a fair value adjustment from €31.85 to €29.24. This reflects recent target cuts from €21 to €15 at JPMorgan, a downgrade to Underweight with a €15 target at Barclays, and a reduction from €26 to €23 at Citi that collectively signal increased caution among analysts.Artículo de análisis • Jan 02
A Look At The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)
Key Insights The projected fair value for LANXESS is €14.85 based on 2 Stage Free Cash Flow to Equity LANXESS' €17.62...Actualización de narrativa • Dec 17
LXS: Demand Recovery And Margin Actions Will Drive Bullish Repricing
Analysts have trimmed their price target on LANXESS to EUR 15 from EUR 21, citing weaker expected revenue growth, lower profit margins, a higher discount rate, and a richer future P E multiple. Together, these factors reduce estimated fair value from about EUR 37.49 to EUR 31.85 per share.Artículo de análisis • Dec 15
Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Actualización de narrativa • Dec 03
LXS: Future Earnings Multiples Will Reward Improving Execution Amid Sector Caution
The analyst fair value estimate for LANXESS has been reduced slightly to EUR 20.30 from EUR 20.92, as analysts factor in lower sector sentiment, a modestly softer revenue growth outlook, and recent cuts to Street price targets across the European chemicals space. Analyst Commentary Street research on LANXESS has turned more cautious, with recent revisions reflecting concerns around sector headwinds, execution risk, and a less supportive valuation backdrop.Actualización de narrativa • Nov 19
LXS: Future Earnings Multiples Will Reflect Sector Caution And Resilient Performance
LANXESS’s analyst price target has been revised downward from €24.55 to €20.92 as analysts cite sector-wide caution and a reassessment of fair value within the European chemicals industry. Analyst Commentary The recent series of updates from street research highlights both supportive and cautious sentiment regarding LANXESS’s outlook, reflecting the evolving landscape in the European chemicals sector.Actualización de narrativa • Nov 05
LXS: Future Resilience Will Support Stability Amid Sector Pressures
Analysts have modestly reduced their price target for LANXESS by approximately EUR 0.30. This adjustment reflects more cautious growth and valuation assumptions in light of recent sector performance and peer comparisons.Actualización de narrativa • Oct 22
Analysts Lower LANXESS Price Target and Ratings Amid Mixed Outlook and Valuation Shifts
The analyst price target for LANXESS has been reduced by approximately EUR 0.67 to EUR 24.85. This change reflects revised expectations on revenue growth and profitability as analysts adjust their outlook in light of recent performance and updated industry assessments.Actualización de narrativa • Oct 08
Portfolio Optimization And Sustainable Initiatives Will Unlock Market Opportunities
The analyst consensus price target for LANXESS has been reduced from €26.79 to €25.52. Analysts cite increased caution due to reduced expected growth and valuation concerns following the company's recent outperformance among peers.Actualización de narrativa • Aug 29
Accelerated FORWARD! Program Set To Improve Future Performance
Analysts have lowered LANXESS's price target to €26.79, citing ongoing operational headwinds, margin pressure, and delayed recovery in key markets, while acknowledging that cost measures will take time to improve earnings. Analyst Commentary Bearish analysts cite persistent near-term operational headwinds and sluggish demand as reasons for lowering price targets.Artículo de análisis • Jul 03
Is LANXESS Aktiengesellschaft (ETR:LXS) Trading At A 46% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, LANXESS fair value estimate is €47.92 LANXESS is estimated to...
Nueva narrativa • Mar 22
Accelerated FORWARD! Program Set To Improve Future Performance
Successful cost savings and portfolio transformation initiatives are boosting profitability, improving margins, and enhancing future earnings potential through strategic divestitures.Artículo de análisis • Mar 07
Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) 25% Share Price Surge
LANXESS Aktiengesellschaft ( ETR:LXS ) shareholders have had their patience rewarded with a 25% share price jump in the...Artículo de análisis • Jan 31
LANXESS (ETR:LXS) Use Of Debt Could Be Considered Risky
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Artículo de análisis • Jan 07
Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Artículo de análisis • Oct 30
Does LANXESS (ETR:LXS) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Artículo de análisis • Sep 07
Why We're Not Concerned About LANXESS Aktiengesellschaft's (ETR:LXS) Share Price
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Artículo de análisis • Jul 23
Is LANXESS (ETR:LXS) Using Debt Sensibly?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Artículo de análisis • May 27
Is It Too Late To Consider Buying LANXESS Aktiengesellschaft (ETR:LXS)?
While LANXESS Aktiengesellschaft ( ETR:LXS ) might not have the largest market cap around , it saw a double-digit share...Artículo de análisis • May 08
Why Investors Shouldn't Be Surprised By LANXESS Aktiengesellschaft's (ETR:LXS) P/S
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.4x is...Artículo de análisis • Apr 20
Is There An Opportunity With LANXESS Aktiengesellschaft's (ETR:LXS) 42% Undervaluation?
Key Insights The projected fair value for LANXESS is €44.32 based on 2 Stage Free Cash Flow to Equity LANXESS is...Artículo de análisis • Mar 22
Is LANXESS (ETR:LXS) Weighed On By Its Debt Load?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Artículo de análisis • Jan 27
What You Can Learn From LANXESS Aktiengesellschaft's (ETR:LXS) P/S
There wouldn't be many who think LANXESS Aktiengesellschaft's ( ETR:LXS ) price-to-sales (or "P/S") ratio of 0.3x is...Artículo de análisis • Dec 05
Is LANXESS (ETR:LXS) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Artículo de análisis • Nov 01
A Look At The Fair Value Of LANXESS Aktiengesellschaft (ETR:LXS)
Key Insights The projected fair value for LANXESS is €20.51 based on Dividend Discount Model Current share price of...Rentabilidad de los accionistas
| LXS | DE Chemicals | Mercado DE | |
|---|---|---|---|
| 7D | 1.4% | -0.3% | -1.5% |
| 1Y | -36.2% | 5.7% | 1.9% |
Rentabilidad vs. Industria: Los resultados de LXS fueron inferiores a los de la industria German Chemicals, que obtuvo un rendimiento del 5.7% el año pasado.
Rentabilidad vs. Mercado: LXS obtuvo unos resultados inferiores a los del mercado German, que fueron del 1.9% el año pasado.
Volatilidad de los precios
| LXS volatility | |
|---|---|
| LXS Average Weekly Movement | 6.5% |
| Chemicals Industry Average Movement | 5.4% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in DE Market | 13.2% |
| 10% least volatile stocks in DE Market | 2.8% |
Precio estable de las acciones: LXS no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado German.
Volatilidad a lo largo del tiempo: La volatilidad semanal de LXS (6%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1863 | 11,630 | Matthias Zachert | lanxess.com |
LANXESS Aktiengesellschaft, junto con sus filiales, opera como una empresa de especialidades químicas que se dedica al desarrollo, fabricación y comercialización de productos químicos intermedios, aditivos, especialidades químicas y productos de protección del consumidor en todo el mundo. Opera a través de tres segmentos: Protección del consumidor, Aditivos especiales e Intermedios avanzados. El segmento de Protección del Consumidor ofrece productos de protección de materiales; soluciones desinfectantes, higiénicas y conservantes; sabores y fragancias; tecnologías de purificación de líquidos para el tratamiento del agua y otros líquidos; y precursores e intermedios para las industrias agroquímica, farmacéutica y de especialidades químicas.
Resumen de fundamentos de LANXESS Aktiengesellschaft
| Estadísticas fundamentales de LXS | |
|---|---|
| Capitalización bursátil | €1.43b |
| Beneficios(TTM) | -€661.00m |
| Ingresos (TTM) | €5.45b |
0.3x
Ratio precio-ventas (PS)-2.1x
Ratio precio-beneficio (PE)¿Está LXS sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de LXS | |
|---|---|
| Ingresos | €5.45b |
| Coste de los ingresos | €4.38b |
| Beneficio bruto | €1.07b |
| Otros gastos | €1.73b |
| Beneficios | -€661.00m |
Últimos beneficios comunicados
Mar 31, 2026
Próxima fecha de beneficios
Aug 07, 2026
| Beneficios por acción (BPA) | -7.66 |
| Margen bruto | 19.65% |
| Margen de beneficio neto | -12.13% |
| Ratio deuda/patrimonio | 71.7% |
¿Cómo se ha desempeñado LXS a largo plazo?
Ver rendimiento histórico y comparativaDividendos
0.6%
Rentabilidad actual por dividendo-1%
Ratio de pagosAnálisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/06/25 21:58 |
| Precio de las acciones al final del día | 2026/06/25 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también contamos con guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
LANXESS Aktiengesellschaft está cubierta por 32 analistas. 15 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| James Knight | Barclays |
| Anil Shenoy | Barclays |
| Andres Castanos-Mollor | Berenberg |